Herbert Eradat
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 39
- Chronic Lymphocytic Leukemia Research 39
-
- Lymphoma Diagnosis and Treatment 33
- Co-authors
- Thomas J. Kipps (6 shared papers)Richard R. Furman (12 shared papers)Ernest Brahn (1 shared paper)Eli E. Sercarz (1 shared paper)Tammy T. Chang (1 shared paper)Radhey S. Gupta (1 shared paper)Kamal D. Moudgil (1 shared paper)Iryna Dyagil (2 shared papers)
- Journals
- Blood (23 papers)Journal of Clinical Oncology (11 papers)Hematological Oncology (6 papers)The Lancet Haematology (2 papers)HemaSphere (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Herbert Eradat
56 papers receiving 979 citations
Peers
Comparison fields: 5 of 59
- Genetics 556
- Pathology and Forensic Medicine 472
- Hematology 161
- Immunology 236
- Oncology 243
Countries citing papers authored by Herbert Eradat
This map shows the geographic impact of Herbert Eradat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Eradat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Eradat more than expected).
Fields of papers citing papers by Herbert Eradat
This network shows the impact of papers produced by Herbert Eradat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Eradat. The network helps show where Herbert Eradat may publish in the future.
Co-authors
The 25 scholars most cited alongside Herbert Eradat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 154 | |
| 2 | 1997 | 114 | |
| 3 | 2018 | 86 | |
| 4 | 2015 | 57 | |
| 5 | 2020 | 43 | |
| 6 | 2016 | 41 | |
| 7 | 2022 | 32 | |
| 8 | 2016 | 30 | |
| 9 | 2019 | 29 | |
| 10 | 2022 | 28 | |
| 11 | 2022 | 28 | |
| 12 | 2011 | 20 | |
| 13 | 2013 | 18 | |
| 14 | 2021 | 18 | |
| 15 | 2016 | 18 | |
| 16 | 2013 | 17 | |
| 17 | 2016 | 17 | |
| 18 | 2023 | 15 | |
| 19 | 2021 | 15 | |
| 20 | 2018 | 15 |
About Herbert Eradat
Herbert Eradat is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 62 papers that have together received 990 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (39 papers), Lymphoma Diagnosis and Treatment (33 papers), Advanced Breast Cancer Therapies (11 papers), CAR-T cell therapy research (11 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). The work is most often cited by research in Genetics (556 citations), Pathology and Forensic Medicine (472 citations), Hematology (161 citations), Immunology (236 citations) and Oncology (243 citations). Herbert Eradat has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Thomas J. Kipps, Richard R. Furman, Ernest Brahn, Eli E. Sercarz, Tammy T. Chang, Radhey S. Gupta, Kamal D. Moudgil, Iryna Dyagil, Halyna Pylypenko and Deborah Hurst. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, The Lancet Haematology and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.